Condensed Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current assets
Cash	$ 444,855	$ 4,710,642
Prepaid and other current assets	375,525	969,763
Total current assets	820,380	5,680,405
Total assets	820,380	5,680,405
Current liabilities
Accounts payable	2,145,739	830,233
Accrued expenses	106,211	177,118
Accrued expenses - compensation		787,981
Total current liabilities	2,251,950	1,795,332
Deferred revenue	500,000	500,000
Total liabilities	2,751,950	2,295,332
Commitments and contingencies (Note 8)
Stockholders’ (Deficit) Equity
Common stock, par value $0.0001; 200,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 10,879,170 and 7,401,242 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively	1,088	740
Additional paid-in capital	57,664,684	55,414,069
Accumulated deficit	(59,597,347)	(52,029,741)
Total stockholders’ (deficit) equity	(1,931,570)	3,385,073
Total liabilities, and stockholders’ (deficit) equity	820,380	5,680,405
Series X Preferred Stock [Member]
Stockholders’ (Deficit) Equity
Series X preferred shares, 500,000 shares authorized as of September 30, 2024 and December 31, 2023; 45,567 shares issued and outstanding at September 30, 2024 and December 31, 2023	$ 5	$ 5

Accrued liabilities excluding employee related liabilities current.

No definition available.

Name:	PXMD_AccruedLiabilitiesExcludingEmployeeRelatedLiabilitiesCurrent
Namespace Prefix:	PXMD_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).